Translesion DNA Synthesis and Hsp90

  • Yamashita Takayuki
    Laboratory of Molecular Genetics, The Institute for Molecular and Cellular Regulation, Gunma University
  • Oda Tsukasa
    Laboratory of Molecular Genetics, The Institute for Molecular and Cellular Regulation, Gunma University
  • Sekimoto Takayuki
    Laboratory of Molecular Genetics, The Institute for Molecular and Cellular Regulation, Gunma University

この論文をさがす

抄録

Translesion DNA synthesis (TLS) is an essential mechanism for DNA damage tolerance during genome duplication by bypassing DNA lesions with use of specialized low-fidelity polymerases. Thus, TLS is inherently mutagenic, which is presumed to be involved in cancer initiation and progression. Increasing attention has focused on post-translational regulatory mechanisms of TLS polymerases, including covalent modification (e.g., phosphorylation) and proteasomal degradation. In this review article, we focus on our findings on Hsp90-mediated regulation of TLS polymerases and discuss potential pharmacological effects of Hsp90 inhibitors in cancer therapy.<br>

収録刊行物

参考文献 (82)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ